New monogenic autoinflammatory diseases—a clinical overview

Seminars in Immunopathology

Volumn 37, Issue 4, 2015, Pages 387-394

  Canna, Scott W ^a   Goldbach Mansky, Raphaela ^a  

^a NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; INTERFERON; INTERLEUKIN 1; INTERLEUKIN 18; PROTEASOME;

AUTOIMMUNITY; AUTOINFLAMMATORY DISEASE; BRAIN CALCIFICATION; CALCIUM SIGNALING; CELL DIFFERENTIATION; CELL MATURATION; CELL STRESS; CLINICAL FEATURE; CYTOKINE PRODUCTION; ENDOTHELIUM; GENE IDENTIFICATION; GENE MUTATION; HUMAN; IMMUNE DEFICIENCY; INTERFERON PRODUCTION; INTERSTITIAL LUNG DISEASE; KERATINOCYTE; LYMPHOCYTE PROLIFERATION; MACROPHAGE ACTIVATION SYNDROME; MYOSITIS; NONHUMAN; PRIORITY JOURNAL; REVIEW; AUTOIMMUNE DISEASES; GENETICS; HEREDITARY AUTOINFLAMMATORY DISEASES; IMMUNOLOGY; INFLAMMATION; METABOLISM; MUTATION; PHENOTYPE; SIGNAL TRANSDUCTION;

AUTOIMMUNE DISEASES; HEREDITARY AUTOINFLAMMATORY DISEASES; HUMANS; INFLAMMATION; INTERFERONS; INTERLEUKIN-18; MACROPHAGE ACTIVATION SYNDROME; MUTATION; PHENOTYPE; PROTEASOME ENDOPEPTIDASE COMPLEX; SIGNAL TRANSDUCTION;

EID: 84943586392     PISSN: 18632297     EISSN: 18632300     Source Type: Journal    
DOI: 10.1007/s00281-015-0493-5     Document Type: Review

References (50)

1. McDermott MF, Aksentijevich I, Galon J et al (1999) Germline mutations in the extracellular domains of the 55 kDa TNF receptor, TNFR1, define a family of dominantly inherited autoinflammatory syndromes. Cell 97:133–144
2. Goldbach-Mansky R, Kastner DL (2009) Autoinflammation: the prominent role of IL-1 in monogenic autoinflammatory diseases and implications for common illnesses. J Allergy Clin Immunol 124:1141–1149, quiz 50-1
3. Gonzalez-Navajas JM, Lee J, David M, Raz E (2012) Immunomodulatory functions of type I interferons. Nat Rev Immunol 12:125–135
4. Schoggins JW, Wilson SJ, Panis M et al (2011) A diverse range of gene products are effectors of the type I interferon antiviral response. Nature 472:481–485
5. Bennett L, Palucka AK, Arce E et al (2003) Interferon and granulopoiesis signatures in systemic lupus erythematosus blood. J ExpMed 197:711–723
6. Agarwal AK, Xing C, DeMartino GN et al (2010) PSMB8 encoding the beta5i proteasome subunit is mutated in joint contractures, muscle atrophy, microcytic anemia, and panniculitis-induced lipodystrophy syndrome. Am J Hum Genet 87:866–872
7. Arima K, Kinoshita A, Mishima H et al (2011) Proteasome assembly defect due to a proteasome subunit beta type 8 (PSMB8) mutation causes the autoinflammatory disorder, Nakajo-Nishimura syndrome. Proc Natl Acad Sci U S A 108:14914–14919
8. Kitamura A, Maekawa Y, Uehara H et al (2011) A mutation in the immunoproteasome subunit PSMB8 causes autoinflammation and lipodystrophy in humans. J Clin Invest 121:4150–4160
9. Liu Y, Ramot Y, Torrelo A et al (2012) Mutations in proteasome subunit beta type 8 cause chronic atypical neutrophilic dermatosis with lipodystrophy and elevated temperature with evidence of genetic and phenotypic heterogeneity. Arthritis Rheum 64:895–907
10. Lu W, Zhang Y, McDonald DO et al (2014) Dual proteolytic pathways govern glycolysis and immune competence. Cell 159:1578–1590
11. Liu Y, Jesus AA, Marrero B et al (2014) Activated STING in a vascular and pulmonary syndrome. N Engl J Med 371:507–518
12. Jeremiah N, Neven B, Gentili M et al (2014) Inherited STINGactivating mutation underlies a familial inflammatory syndrome with lupus-like manifestations. J Clin Invest 124:5516–5520
13. Aicardi J, Goutieres F (1984) A progressive familial encephalopathy in infancy with calcifications of the basal ganglia and chronic cerebrospinal fluid lymphocytosis. Ann Neurol 15:49–54
14. Crow YJ, Chase DS, Lowenstein Schmidt J et al (2015) Characterization of human disease phenotypes associated with mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, ADAR, and IFIH 1. Am J Med Genet A 167A:296–312
15. Rice GI, del Toro Duany Y, Jenkinson EM et al (2014) Gain-offunction mutations in IFIH1 cause a spectrum of human disease phenotypes associated with upregulated type I interferon signaling. Nat Genet 46:503–509
16. Bogunovic D, Byun M, Durfee LA et al (2012) Mycobacterial disease and impaired IFN-gamma immunity in humans with inherited ISG15 deficiency. Science 337:1684–1688
17. Zhang X, Bogunovic D, Payelle-Brogard B et al (2015) Human intracellular ISG15 prevents interferon-alpha/beta overamplification and auto-inflammation. Nature 517:89–93
18. Briggs TA, Rice GI, Daly S et al (2011) Tartrate-resistant acid phosphatase deficiency causes a bone dysplasia with autoimmunity and a type I interferon expression signature. Nat Genet 43:127–131
19. Lausch E, Janecke A, Bros M et al (2011) Genetic deficiency of tartrate-resistant acid phosphatase associated with skeletal dysplasia, cerebral calcifications and autoimmunity. Nat Genet 43:132–137
20. Stepp SE, Dufourcq-Lagelouse R, Le Deist F et al (1999) Perforin gene defects in familial hemophagocytic lymphohistiocytosis. Science 286:1957–1959
21. Pachlopnik Schmid J, Cote M, Menager MM et al (2010) Inherited defects in lymphocyte cytotoxic activity. Immunol Rev 235:10–23
22. Villanueva J, Lee S, Giannini EH et al (2005) Natural killer cell dysfunction is a distinguishing feature of systemic onset juvenile rheumatoid arthritis and macrophage activation syndrome. Arthritis Res Ther 7:R30–R37
23. Kaufman KM, Linghu B, Szustakowski JD et al (2014) Whole-exome sequencing reveals overlap between macrophage activation syndrome in systemic juvenile idiopathic arthritis and familial hemophagocytic lymphohistiocytosis. Arthritis Rheumatol 66:3486–3495
24. Rose NR, Hamilton RG, Detrick B (2002) Manual of clinical laboratory immunology, 6th edn. ASM Press, Washington D.C
25. Romberg N, Al Moussawi K, Nelson-Williams C, et al. (2014) Mutation of NLRC4 causes a syndrome of enterocolitis and autoinflammation. Nat Genet 46:1135–1139
26. Canna SW, de Jesus AA, Gouni S, et al. (2014) An activating NLRC4 inflammasome mutation causes autoinflammation with recurrent macrophage activation syndrome. Nat Genet 46:1140–1146
27. Ichida H, Kawaguchi Y, Sugiura T, et al. (2013) Clinical manifestations of adult-onset still's disease presenting with erosive arthritis: association with low levels of ferritin and IL-18. Arthritis care & Res 66:642–646
28. Shimizu M, Nakagishi Y, Yachie A (2013) Distinct subsets of patients with systemic juvenile idiopathic arthritis based on their cytokine profiles. Cytokine 61:345–348
29. Kitamura A, Sasaki Y, Abe T, Kano H, Yasutomo K (2014) An inherited mutation in NLRC4 causes autoinflammation in human and mice. J Exp Med 211:2385–2396
30. Rigaud S, Fondaneche MC, Lambert N et al (2006) XIAP deficiency in humans causes an X-linked lymphoproliferative syndrome. Nature 444:110–114
31. Marsh RA, Madden L, Kitchen BJ et al (2010) XIAP deficiency: a unique primary immunodeficiency best classified as X-linked familial hemophagocytic lymphohistiocytosis and not as X-linked lymphoproliferative disease. Blood 116:1079–1082
32. Aguilar C, Lenoir C, Lambert N, et al. (2014) Characterization of Crohn disease in X-linked inhibitor of apoptosis-deficient male patients and female symptomatic carriers. J allergy and Clin Immunol 134:1131–1141
33. Speckmann C, Lehmberg K, Albert MH et al (2013) X-linked inhibitor of apoptosis (XIAP) deficiency: the spectrum of presenting manifestations beyond hemophagocytic lymphohistiocytosis. Clin Immunol 149:133–141
34. Wada T, Kanegane H, Ohta K et al (2014) Sustained elevation of serum interleukin-18 and its association with hemophagocytic lymphohistiocytosis in XIAP deficiency. Cytokine 65:74–78
35. Damgaard RB, Gyrd-Hansen M (2011) Inhibitor of apoptosis (IAP) proteins in regulation of inflammation and innate immunity. Discovery Med 11:221–231
36. Damgaard RB, Nachbur U, Yabal M et al (2012) The ubiquitin ligase XIAP recruits LUBAC for NOD2 signaling in inflammation and innate immunity. Mol Cell 46:746–758
37. de Jesus AA, Canna SW, Liu Y, Goldbach-Mansky R. (2015) Molecular mechanisms in genetically defined autoinflammatory diseases: disorders of amplified danger signaling. Annu Rev Immunol 33:823–874
38. Yabal M, Muller N, Adler H et al (2014) XIAP restricts TNF- and RIP3-dependent cell death and inflammasome activation. Cell Reports 7:1796–1808
39. Jordan CT, Cao L, Roberson ED et al (2012) Rare and common variants in CARD14, encoding an epidermal regulator of NFkappaB, in psoriasis. Am J Hum Genet 90:796–808
40. Jordan CT, Cao L, Roberson ED et al (2012) PSORS2 is due to mutations in CARD 14. Am J Hum Genet 90:784–795
41. Fuchs-Telem D, Sarig O, van Steensel MA et al (2012) Familial pityriasis rubra pilaris is caused by mutations in CARD 14. Am J Hum Genet 91:163–170
42. Eytan O, Sarig O, Sprecher E, van Steensel MA (2014) Clinical response to ustekinumab in familial pityriasis rubra pilaris caused by a novel mutation in CARD 14. British J Dermatol 171:420–422
43. Zhou Q, Yang D, Ombrello AK et al (2014) Early-onset stroke and vasculopathy associated with mutations in ADA 2. N Engl J Med 370:911–920
44. Navon Elkan P, Pierce SB, Segel R et al (2014) Mutant adenosine deaminase 2 in a polyarteritis nodosa vasculopathy. N Engl J Med 370:921–931
45. Chakraborty PK, Schmitz-Abe K, Kennedy EK et al (2014) Mutations in TRNT1 cause congenital sideroblastic anemia with immunodeficiency, fevers, and developmental delay (SIFD). Blood 124:2867–2871
46. Wiseman DH, May A, Jolles S et al (2013) A novel syndrome of congenital sideroblastic anemia, B-cell immunodeficiency, periodic fevers, and developmental delay (SIFD). Blood 122:112–123
47. Sasarman F, Thiffault I, Weraarpachai W, et al. (2015) The 3' addition of CCA to mitochondrial tRNASer(AGY) is specifically impaired in patients with mutations in the tRNA nucleotidyl transferase TRNT 1. Human Mol genet 24:2841–2847
48. Ombrello MJ, Remmers EF, Sun G et al (2012) Cold urticaria, immunodeficiency, and autoimmunity related to PLCG2 deletions. N Engl J Med 366:330–338
49. Chae JJ, Park YH, Park C, et al. (2014) Connecting two pathways through Ca signaling: NLRP3 inflammasome activation induced by a hypermorphic PLCG2 mutation. Arthritis & Rheumatol 67:563–567
50. Livingston JH, Lin JP, Dale RC et al (2014) A type I interferon signature identifies bilateral striatal necrosis due to mutations in ADAR 1. J Med Genet 51:76–82